Aurora Cannabis Inc. Common Shares (ACB)
Aurora Cannabis Inc. is a Canadian company specializing in the production and sale of medical and recreational cannabis products. Established in 2006, it is one of the leading players in the global cannabis industry, with a large-scale cultivation and processing operation. Aurora focuses on innovative cannabis solutions, research, and development to serve both medicinal and adult-use markets worldwide.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 31, 2007 | $0.16 | 2007-12-19 | 2007-12-21 |
| December 31, 2007 | $0.01 | 2007-12-19 | 2007-12-21 |
| December 31, 2007 | $0.03 | 2007-12-19 | 2007-12-21 |
Dividends Summary
- Aurora Cannabis Inc. Common Shares has issued 3 dividend payments over the past 0 years
- The most recent dividend was paid 6490 days ago, on December 31, 2007
- The highest dividend payed out to investors during this period was $0.16 per share
- The average dividend paid during this period was $0.07 per share.
Company News
A video posted on Truth Social by the Commonwealth Project suggests potential federal marijuana legalization, with implications for Medicare coverage of medical marijuana and significant stock market reactions in cannabis companies.
Donald Trump's video on Truth Social praising hemp-derived CBD's health benefits triggered a significant surge in cannabis and CBD-related stocks, with some companies experiencing dramatic price increases.
President Trump posted a video on Truth Social promoting CBD's potential health benefits, suggesting Medicare coverage and potential healthcare system integration. This sparked a significant rally in cannabis stocks, with multiple companies seeing substantial price increases.
The global medical marijuana market is projected to grow from $30 billion in 2025 to $80 billion by 2032, driven by evolving regulations, increased healthcare acceptance, and therapeutic potential for managing conditions like chronic pain and mental health disorders.
Aurora Cannabis (ACB) delivered earnings and revenue surprises of 161.11% and 2.54%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
